Global Radiosurgical System Market Overview:
Radiosurgery uses many specifically focused radiation beams to treat tumors and other problems in the brain, neck, lungs, liver, spine and other parts of the body. It is not surgery in the traditional sense because there's no cut it uses 3D imaging to target high doses of radiation to the affected area with minimal impact on the surrounding healthy tissue. The radiosurgery focus beams of radiation like gamma rays, X-rays, or protons are wont to treat cancerous tissues without a incision or opening. As other sorts of therapeutic radiology the radiosurgery works in the same manner because it destroys the DNA of tumor cells, causing them to be unable to grow.
Growth Drivers
- Growing Prevalence of Cancer and Related Diseases
- Rising Demand for Personalized Radiation Treatments
Market Trends
- Introduction of Technically Advanced Radiotherapy Devices
Roadblocks
- Lack of Trained Personnel to Operate Stereotactic Radiotherapy Devices
- High Cost and Difficulty in Accessibility of Treatment
Opportunities
- Growing Expenditure by Governments to Prevent Cancer
- Increasing Awareness about the Importance of Radiotherapy Treatment
Challenges
- Complexity Involved in Radiotherapy Techniques and Risk of Exposure of Radiation
Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Varian Medical Systems (United States), American Radiosurgery Inc. (United States), Elekta (Sweden), Surrer Health (United States), Accuray (United States), ViewRay, Inc. (United States), Isoray, Inc. (United States), Hitachi, Ltd. (Japan), C. R. Bard, Inc. (United States), Panacea Medical Technologies Pvt. Ltd. (India) and Optivus Proton Therapy, Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Radiosurgical System market by 2025. Considering Market by End-User, the sub-segment i.e. Clinics will boost the Radiosurgical System market.
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Radiosurgical System market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Radiosurgical System market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Radiosurgical System, Suppliers of Radiosurgical System, Wholesalers, Distributors and Retailers of Radiosurgical System, End-Users, Regulatory Bodies and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.